Recent Finacing
Recent Raise
BrainEver is a biopharmaceutical company developing homeoprotein-based therapies to halt neurodegenerative disease progression in indications such as ALS, Parkinson’s disease and retinal disorders.
Focus Areas
Total Raised
Funding round
See the team members at BrainEver.
